Idéal Investisseur
Français English
CAC 40 : Market open
8 178,32 pts
-0.31%


Last updated : 10/06/2026 - 12h40
🏠 Home   ➤    Stock news

EMEIS: EBITDAR Up by 19%, Yet a Net Loss of €298M Continues

EMEIS confirms its exit from the safeguard plan by displaying a sharp operational rebound in 2025: EBITDAR increases by 19.2% on a like-for-like basis, nursing home occupancy improves by 2 points, and resident satisfaction reaches its highest level in three years. Meanwhile, the refinancing of €3.15 billion and asset disposals reduce debt by €1 billion. However, the group records a net loss of €298 million, revealing the ongoing cost of financial restructuring despite an improvement of €114 million year-on-year.


EMEIS: EBITDAR Up by 19%, Yet a Net Loss of €298M Continues

Operational Performance and Revenue Growth

The key indicator of nursing home occupancy rate increased by 2.0 points over twelve months to reach 87.2% at the end of 2025, compared to 85.2% at the end of 2024. This positive momentum supports an organic revenue growth of 6.1%, fueled by a tariff increase of 3.3% and contributions from new facilities. EBITDAR recorded a rise of 19.2% on a like-for-like basis, thus exceeding the provided guidance (between +15% and +18%). This outperformance is driven by all business sectors and regions, particularly France (+15%) and Germany. The EBITDAR margin widened by 1.7 points to 14.8% of revenues, reaching 15.8% in the second half of the year. Operating income (EBIT) increased by €171 million to €173 million, compared to €2 million the previous year.

Non-Financial Indicators and Resident Satisfaction

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Non-financial indicators reflect a sustainable restoration of trust. The resident satisfaction rate stood at 93.4% at the end of 2025, up by 40 basis points year-on-year and more than 300 points since 2022. The Net Promoter Score (NPS) of residents jumped to 41, from 18 at the end of 2022. These improvements are accompanied by a decrease in the rates of bedsores (1.9% versus 2.2%) and physical restraints (11.2% versus 13.1%). Concurrently, non-recurring expenses increased by €85 million, fueled by the closures of certain facilities in France, Belgium, and Germany, as well as by refinancing costs and the creation of Isemia company. As a result, the net loss improved by €114 million to -€298 million, but remains significantly negative.

Refinancing and Debt Reduction

EMEIS finalizes a refinancing of €3.15 billion with an average maturity of 5.5 years, allowing the full repayment of its previous bank debt. Asset disposals and the Isemia real estate partnership generated €2.35 billion since mid-2022, significantly exceeding the initial target of €1.5 billion. Net debt (excluding IFRS 16, 5, and 9) decreased by €1 billion to reach €3.78 billion on an Isemia proforma basis. The leverage ratio (net debt / EBITDA) improved markedly to 9.9x (proforma) from 19.5x at the end of 2024. For 2026, the group anticipates an EBITDAR growth exceeding 10% on a like-for-like basis and confirms its target of average annual growth between +12% and +16% over 2024-2028. The capital structure has gained strength, with an average debt cost of 4.9% and an average maturity of 5.1 years.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext

Contexte

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 1509M€
Risks mentioned
  • Les mesures de qualité engagées en 2024 et 2025 sont essentielles.
  • La demande de lits devrait dépasser l'offre de 550 000 d'ici 2030.
Opportunities identified
  • Croissance organique de +6,3 % au 1T2026, soutenue par des taux d'occupation améliorés.
  • Réduction de la sensibilité aux pressions inflationnistes grâce à un hedging sur 90 % des dépenses énergétiques.

Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.

Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.

Annonce
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours